Splenic flexure colon cancer may represent a distinct prognostic subtype associated with elevated systemic inflammation and impaired nutritional status - Takeaways - MDSpire

Splenic flexure colon cancer may represent a distinct prognostic subtype associated with elevated systemic inflammation and impaired nutritional status

  • By

  • Zhi-Hua Yang

  • Yue Peng

  • Rong Shang

  • Xiao-Yan Tang

  • Yi-Wu Zhou

  • Xiao-Juan Li

  • Yu-Cui Liao

  • June 9, 2026

  • 0 min

Share

  • 1

    Splenic flexure colon cancer (SFCC) is a rare malignancy with distinct anatomical features and clinical behavior.

  • 2

    Patients with SFCC exhibit significantly worse recurrence-free survival and overall survival compared to those with other colon cancer locations.

  • 3

    The nutrition-inflammation integrating index (NII) is identified as an independent prognostic factor for overall survival in SFCC patients.

  • 4

    SFCC is characterized by higher TNM stage, lymph metastasis, large tumor size, poor differentiation, and inflammation-nutrition imbalance.

  • 5

    Further large-scale studies are needed to validate the findings regarding SFCC's unique prognostic features and the role of NII.

Original Source(s)

Splenic flexure colon cancer may represent a distinct prognostic subtype associated with elevated systemic inflammation and impaired nutritional status

  • by Zhi-Hua Yang, Yue Peng, Rong Shang, Xiao-Yan Tang, Yi-Wu Zhou, Xiao-Juan Li, Yu-Cui Liao

  • June 9, 2026

Related Content

Tislelizumab combined with gemcitabine as first-line treatment in cisplatin-ineligible patients with locally advanced or metastatic urothelial carcinoma: a single center, single-arm phase 2 trial

Editorial: Metabolic cell death in cancer: innovative therapeutic avenues for cancer treatment

First-line serplulimab plus chemotherapy versus chemotherapy alone in small-cell lung cancer patients with brain metastases: a multicenter, prospective cohort study